Tvm Life Science Ventures Vii L.P.

Avg. Two Year Performance

(79%) Avg. Purchase Return

(34%) Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	78%	13%	33%	(85%)	(79%)
Purchase Success Rate	1 of 1	1 of 1	1 of 1	0 of 1	0 of 1
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Opexa Therapeutics, Inc.

Drugs » Biotechnology

Director, 10% Owner:

Holdings: 1.7M shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--